Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-chloro-N-(6-ethoxy-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-chloro-N-(6-methoxy-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-chloro-N-(6-methyl-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-chloro-N-(6-nitro-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-fluoro-N-(6-nitro-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-methoxy-N-(6-methoxy-1,3-benzothiazol -2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-methoxy-N-(6-methyl-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-methoxy-N-(6-nitro-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-methyl-N-(6-methyl-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-methyl-N-(6-nitro-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
4-nitro-N-(6-nitro-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
benzenesulfonamide | - |
Rattus norvegicus | |
additional information | inhibitor docking studies with PTP-1B, overview | Rattus norvegicus | |
N-(4-([(6-ethoxy-1,3-benzothiazol-2-yl)amino]sulfonyl)phenyl)acetamide | - |
Rattus norvegicus | |
N-(4-([(6-methoxy-1,3-benzothiazol-2-yl)amino]sulfonyl)phenyl)acetamide | - |
Rattus norvegicus | |
N-(4-([(6-methyl-1,3-benzothiazol-2-yl)amino]sulfonyl)phenyl)acetamide | - |
Rattus norvegicus | |
N-(4-[[(6-nitro-1,3-benzothiazol-2-yl)amino]sulfonyl]-phenyl)acetamide | - |
Rattus norvegicus | |
N-(6-chloro-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxybenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methylbenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-nitrobenzene sulfonamide | linear mixed-type inhibition, shows in vivo antihyperglycemic activity | Rattus norvegicus | |
N-(6-ethoxy-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
N-(6-fluoro-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-methylbenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-methoxy-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | - |
Rattus norvegicus | |
N-(6-methoxy-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus | |
N-(6-methyl-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | linear mixed-type inhibition, shows in vivo antihyperglycemic activity | Rattus norvegicus | |
N-(6-methyl-1,3-benzothiazol-2-yl)benzenesulfonamide | - |
Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
male Wistar rats | - |
Synonyms | Comment | Organism |
---|---|---|
protein tyrosine phosphatase 1B | - |
Rattus norvegicus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0071 | - |
N-(6-methyl-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | - |
Rattus norvegicus | |
0.0204 | - |
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-nitrobenzene sulfonamide | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0195 | - |
- |
Rattus norvegicus | N-(6-methyl-1,3-benzothiazol-2-yl)-4-nitrobenzenesulfonamide | |
0.0409 | - |
- |
Rattus norvegicus | N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-nitrobenzene sulfonamide |